A standardized pathology report for gastric cancer: 2nd edition

• Published in: Journal of pathology and translational medicine Vol. 57; no. 1; pp. 1 - 27
• Main Authors: Park, Young Soo, Kook, Myeong-Cherl, Kim, Baek-Hui, Lee, Hye Seung, Kang, Dong-Wook, Gu, Mi-Jin, Shin, Ok Ran, Choi, Younghee, Lee, Wonae, Kim, Hyunki, Song, In Hye, Kim, Kyoung-Mee, Kim, Hee Sung, Kang, Guhyun, Park, Do Youn, Jin, So-Young, Kim, Joon Mee, Choi, Yoon Jung, Chang, Hee Kyung, Ahn, Soomin, Chang, Mee Soo, Han, Song-Hee, Kwak, Yoonjin, Seo, An Na, Cho, Mee-Yon
• Format: Journal Article
• Language: English; Chinese
• Published: Korea (South) Korean Society of Pathologists, Korean Society for Cytopathology 01.01.2023; The Korean Society of Pathologists and the Korean Society for Cytopathology; Korean Society of Pathologists & the Korean Society for Cytopathology
• Subjects: Biomarkers; Cancer therapies; Chemotherapy; Classification; Committees; endoscopic resection; Endoscopy; gastrectomy; Gastric cancer; Gastrointestinal surgery; Lymphatic system; Medical prognosis; molecular pathology; Mortality; Pathology; pathology report; Review; standardization; stomach neoplasms; Tumors; Molecular pathology; Pathology report; Endoscopic resection; Gastrectomy; Stomach neoplasms; Standardization
• ISSN: 2383-7837; 2383-7845
• DOI: 10.4132/jptm.2022.12.23

The first edition of 'A Standardized Pathology Report for Gastric Cancer' was initiated by the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists and published 17 years ago. Since then, significant advances have been made in the pathologic diagnosis, molecular genetics, and management of gastric cancer (GC). To reflect those changes, a committee for publishing a second edition of the report was formed within the Gastrointestinal Pathology Study Group of the Korean Society of Pathologists. This second edition consists of two parts: standard data elements and conditional data elements. The standard data elements contain the basic pathologic findings and items necessary to predict the prognosis of GC patients, and they are adequate for routine surgical pathology service. Other diagnostic and prognostic factors relevant to adjuvant therapy, including molecular biomarkers, are classified as conditional data elements to allow each pathologist to selectively choose items appropriate to the environment in their institution. We trust that the standardized pathology report will be helpful for GC diagnosis and facilitate large-scale multidisciplinary collaborative studies.